Autopsy report · NCT02206776

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

“poor tolerability and low enrollment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 8 months before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 1 year 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

New York State Psychiatric Institute

Sponsor type

University, hospital or other

Conditions

Obsessive-Compulsive Disorder

Interventions

Intranasal Ketamine; Intranasal Midazolam

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis
  “low-rate of enrollment” (78% match in meaning)
• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (78% match in meaning)
• An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients.
  “Low enrollment rate” (75% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (74% match in meaning)
• Bile Acids in Acute Insulin Resistance
  “Poor enrollment” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.